Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zayd Tippu

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
European Urology Oncology|September 26, 2024
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future DirectionsLaura Marandino, Riccardo Campi, Daniele Amparore, et al.
European Journal of Cancer (Oxford, England : 1990)|July 14, 2020
Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancerVasileios Angelis, Zayd Tippu, Kroopa Joshi, et al.
Cancer Discovery|May 2, 2025
MANIFEST: Multiomic Platform for Cancer ImmunotherapyKok Haw Jonathan Lim, Zayd Tippu, Pippa G Corrie, et al.
European Urology Open Science|January 15, 2026
Long-term Real-world Survival Outcomes with Dual Immune Checkpoint Blockade in Synchronous Metastatic Renal Cell Carcinoma: Implications for the Design of Prospective Cytoreductive Nephrectomy TrialsLeo Bickley, Elisabeth E Fransen van de Putte, Luna van den Brink, et al.
European Urology Open Science|June 17, 2026
Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141]Leo Bickley, Elisabeth E Fransen van de Putte, Luna van den Brink, et al.
Cancer Discovery|January 9, 2025
Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx RenalÁngel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, et al.
Cell Reports|May 7, 2020
Representative Sequencing: Unbiased Sampling of Solid Tumor TissueKevin Litchfield, Stacey Stanislaw, Lavinia Spain, et al.
Cancer Discovery|January 8, 2025
Tracking non-genetic evolution from primary to metastatic ccRCC: TRACERx RenalÁngel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, et al.
Cancer Cell|April 28, 2023
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancerMary Y Wu, Scott T C Shepherd, Annika Fendler, et al.
Cell Reports. Medicine|October 14, 2022
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancerAnnika Fendler, Scott T C Shepherd, Lewis Au, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
European Urology Oncology|September 26, 2024
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future DirectionsLaura Marandino, Riccardo Campi, Daniele Amparore, et al.
European Journal of Cancer (Oxford, England : 1990)|July 14, 2020
Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancerVasileios Angelis, Zayd Tippu, Kroopa Joshi, et al.
Cancer Discovery|May 2, 2025
MANIFEST: Multiomic Platform for Cancer ImmunotherapyKok Haw Jonathan Lim, Zayd Tippu, Pippa G Corrie, et al.
European Urology Open Science|January 15, 2026
Long-term Real-world Survival Outcomes with Dual Immune Checkpoint Blockade in Synchronous Metastatic Renal Cell Carcinoma: Implications for the Design of Prospective Cytoreductive Nephrectomy TrialsLeo Bickley, Elisabeth E Fransen van de Putte, Luna van den Brink, et al.
European Urology Open Science|June 17, 2026
Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141]Leo Bickley, Elisabeth E Fransen van de Putte, Luna van den Brink, et al.
Cancer Discovery|January 9, 2025
Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx RenalÁngel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, et al.
Cell Reports|May 7, 2020
Representative Sequencing: Unbiased Sampling of Solid Tumor TissueKevin Litchfield, Stacey Stanislaw, Lavinia Spain, et al.
Cancer Discovery|January 8, 2025
Tracking non-genetic evolution from primary to metastatic ccRCC: TRACERx RenalÁngel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, et al.
Cancer Cell|April 28, 2023
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancerMary Y Wu, Scott T C Shepherd, Annika Fendler, et al.
Cell Reports. Medicine|October 14, 2022
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancerAnnika Fendler, Scott T C Shepherd, Lewis Au, et al.
Pageof 3